Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
VAGUS-NERVE-LIKE PARASYMPATHETIC NERVE CELL, AND METHOD FOR PRODUCING SAME
Document Type and Number:
WIPO Patent Application WO/2024/024955
Kind Code:
A1
Abstract:
Provided is a method for producing a vagus-nerve-like parasympathetic nerve cell, the method comprising (a) a step for inducing the differentiation of a pluripotent stem cell into a parasympathetic nerve cell, and (b1) a step for introducing an exogenous nucleic acid encoding a gastrointestinal hormone receptor into the pluripotent stem cell prior to the step (a) or (b2) a step for introducing an exogenous nucleic acid encoding a gastrointestinal hormone receptor into the parasympathetic nerve cell produced by the step (a) or a progenitor cell thereof. Also provided is a brain-gut interaction model comprising a vagus-nerve-like parasympathetic nerve cell produced by the aforementioned method and a gastrointestinal hormone secreting cell.

Inventors:
KIDA YASUYUKI (JP)
TAKAYAMA YUZO (JP)
NIMIYA AKAGI YUKA (JP)
YAMASHITA AZUSA (JP)
YOSHIKADO RISA (JP)
MIYAMOTO YASUHISA (JP)
Application Number:
PCT/JP2023/027801
Publication Date:
February 01, 2024
Filing Date:
July 28, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
AIST (JP)
ASAHI GROUP HOLDINGS LTD (JP)
International Classes:
C12N5/0793; C12N5/10; C12N15/12; C12Q1/02; G01N33/483; G01N33/50
Domestic Patent References:
WO2020040286A12020-02-27
WO2016194522A12016-12-08
Other References:
BERTHOUD H.‐R.: "Vagal and hormonal gut–brain communication: from satiation to satisfaction", NEUROGASTROENTEROLOGY AND MOTILITY, BLACKWELL SCIENTIFIC PUBLICATIONS, OXFORD, GB, vol. 20, no. s1, 1 May 2008 (2008-05-01), GB , pages 64 - 72, XP093133520, ISSN: 1350-1925, DOI: 10.1111/j.1365-2982.2008.01104.x
DATABASE Nucleotide 26 June 2022 (2022-06-26), ANONYMOUS : "Homo sapiens glucagon like peptide 1 receptor (GLP1R), transcript variant 1, mRNA", XP093133523, retrieved from NCBI Database accession no. NM_002062.5
DATABASE Nucleotide 26 June 2021 (2021-06-26), ANONYMOUS M : "Homo sapiens neuropeptide Y receptor Y2 (NPY2R), transcript variant 1, mRNA", XP093133525, retrieved from NCBI Database accession no. NM_000910.4
DATABASE Nucleotide 9 August 2021 (2021-08-09), ANONYMOUS : "Homo sapiens glucagon like peptide 2 receptor (GLP2R), mRNA", XP093133529, retrieved from NCBI Database accession no. NM_004246.3
DATABASE Nucleotide 25 July 2022 (2022-07-25), ANONYMOUS : "Homo sapiens 5-hydroxytryptamine receptor 3A (HTR3A), transcript variant 1, mRNA", XP093133531, retrieved from NCBI Database accession no. NM_213621.4
DATABASE Nucleotide 20210627; ANONYMOUS : "Homo sapiens cholecystokinin A receptor (CCKAR), mRNA ", XP093133534, retrieved from NCBI Database accession no. NM_000730.3
MINAGAWA ATSUTAKA; YOSHIKAWA TOSHIAKI; YASUKAWA MASAKI; HOTTA AKITSU; KUNITOMO MIHOKO; IRIGUCHI SHOICHI; TAKIGUCHI MAIKO; KASSAI Y: "Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy", CELL STEM CELL, ELSEVIER, CELL PRESS, AMSTERDAM, NL, vol. 23, no. 6, 6 December 2018 (2018-12-06), AMSTERDAM, NL , pages 850, XP085555973, ISSN: 1934-5909, DOI: 10.1016/j.stem.2018.10.005
Attorney, Agent or Firm:
OKUYAMA, Shoichi et al. (JP)
Download PDF: